2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2019 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2015 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2011 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | 800-900 |
Total number of projects: 7
As coordinator: 0
As participant: 6
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 4.000.000 | 17.704 | 1 | ||
2019 | 0 | 3.915.903 | 229.715 | 1 | ||
2015 | 0 | 10.418.607 | 281.313 | 2 | ||
2011 | 100.000 | 13.998.410 | 204.052 | 1 | 2 |
Total number of partners: 140
Partner loyalty:
Frequent Partner: (> 2 projects): 12
Rare Partner: 128
Frequent / Rare Partner Ratio: 0.09
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-06-01 | Beyond 1M Genomes | B1MG | participant | 4.000.000 | 37 |
2019-11-01 | Small-Molecule Drug Conjugates for Targeted Delivery in Tumor Therapy | Magicbullet Reloaded | participant | 3.915.903 | 15 |
2015-01-01 | ERA-NET: Aligning national/regional translational cancer research programmes and activities | TRANSCAN-2 | participant | 6.672.187 | 28 |
2015-01-01 | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | MAGICBULLET | participant | 3.746.420 | 9 |
2011-06-01 | Roles of Hydrogen Sulfide and its Metabolites in Neutrophil Function and Redox Signaling | NHS | coordinator | 100.000 | 1 |
2011-01-01 | A European Platform for Translational Cancer Research | EUROCANPLATFORM | participant | 11.998.454 | 28 |
2011-01-01 | ERA-NET on Translational Cancer Research | TRANSCAN | participant | 1.999.956 | 29 |